84 related articles for article (PubMed ID: 1363758)
1. [Comparison of radiometric, immunometric, and immunohistochemical methods for the determination of hormonal receptors and quality control of other prognostic parameters in the characterization of carcinoma of the breast].
Piffanelli A; Pelizzola D; Giovannini G; Catozzi L; Uccelli L; Barozzi R; Giganti M
Pathologica; 1992; 84(1094):61-4. PubMed ID: 1363758
[No Abstract] [Full Text] [Related]
2. Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer.
Iwase H; Itoh Y; Kuzushima T; Yamashita H; Iwata H; Toyama T; Hara Y; Kobayashi S
Cancer Detect Prev; 1997; 21(1):29-35. PubMed ID: 9043760
[TBL] [Abstract][Full Text] [Related]
3. Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy.
Tonkin KS; McKay JW; Stitt LW; Tokmakejian S; Haines DS
Cancer Prev Control; 1999 Apr; 3(2):131-6. PubMed ID: 10474760
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors in breast cancer patients].
Roisman I; Peretz T; Reznick AZ; Lifshitz I; Bitterman A; Fares F; Toledano H; Barzilay A; Durst AL
Harefuah; 1996 May; 130(10):693-9. PubMed ID: 8794662
[No Abstract] [Full Text] [Related]
5. Application of image analysis to the evaluation of cellular prognostic factors in breast carcinoma.
Bacus SS; Ruby SG
Pathol Annu; 1993; 28 Pt 1():179-204. PubMed ID: 8093211
[No Abstract] [Full Text] [Related]
6. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
[No Abstract] [Full Text] [Related]
7. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay.
Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
Jpn J Clin Oncol; 1994 Apr; 24(2):74-8. PubMed ID: 7908994
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
[TBL] [Abstract][Full Text] [Related]
9. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
10. [Value of detection of hormone receptors by biochemical and immunochemical methods in therapeutic decision for breast cancer].
Goussard J
Bull Cancer; 1996 Dec; 83(12):1031-6. PubMed ID: 9116370
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers.
Koenders PG; Beex LV; Geurts-Moespot A; Heuvel JJ; Kienhuis CB; Benraad TJ
Cancer Res; 1991 Sep; 51(17):4544-8. PubMed ID: 1873798
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
Ioachim EE; Athanassiadou SE; Kamina S; Carassavoglou K; Agnantis NJ
Anticancer Res; 1998; 18(3A):1665-70. PubMed ID: 9673387
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical detection of estradiol and progesterone receptors in paraffin sections after treatment with microwaves. Comparison with biochemical assay of receptors in a series of 123 breast cancers with determination of the threshold of optimal positivity].
Vilain MO; Delobelle-Deroide A; Bloget F; Cabaret V; Peyrat JP; Fournier C; Hecquet B; Fournier J; Vennin P; Bonneterre J
Ann Pathol; 1997 Apr; 17(2):82-8. PubMed ID: 9221007
[No Abstract] [Full Text] [Related]
14. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
[TBL] [Abstract][Full Text] [Related]
15. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
[TBL] [Abstract][Full Text] [Related]
16. [Cathepsin D: an independent prognostic factor in cancer of the breast].
Romain S; Muracciole X; Varette I; Bressac C; Brandone H; Martin PM
Bull Cancer; 1990; 77(5):439-47. PubMed ID: 2400813
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
Göhring UJ; Ahr A; Scharl A; Weisner V; Neuhaus W; Crombach G; Holt JA
J Soc Gynecol Investig; 1995; 2(4):653-9. PubMed ID: 9420872
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.
Scorilas A; Yotis J; Gouriotis D; Keramopoulos A; Ampela K; Trangas T; Talieri M
Anticancer Res; 1993; 13(5C):1895-900. PubMed ID: 7903524
[TBL] [Abstract][Full Text] [Related]
19. Relationships between epidermal growth factor receptor (EGF-R) and other predictors of prognosis in breast carcinomas. An immunohistochemical study.
Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
Pathologica; 1993; 85(1100):637-44. PubMed ID: 8170712
[TBL] [Abstract][Full Text] [Related]
20. Comparison of EGFR, c-erbB-2 product and ras p21 immunohistochemistry as prognostic markers in primary breast cancer.
Hainsworth PJ; Henderson MA; Stillwell RG; Bennett RC
Eur J Surg Oncol; 1991 Feb; 17(1):9-15. PubMed ID: 1671658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
